Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients

Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients

(2010) Markus Bickel et al.   AIDS

AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age

(2010) François Roman et al.   CLINICAL INFECTIOUS DISEASES

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study

(2010) Elizabeth Miller et al.   LANCET

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

(2010) Deepali Kumar et al.   LANCET INFECTIOUS DISEASES

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Influenza Immunization on Humoral and Cellular Alloreactivity in Humans

(2010) Lara Danziger-Isakov et al.   TRANSPLANTATION

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months

(2010) Alfonso Carmona et al.   VACCINE

Guidance on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients†

(2009) D. Kumar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients

(2009) S Candon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children

(2009) Paula Lister et al.   LANCET

H1N1 2009 influenza virus infection during pregnancy in the USA

(2009) Denise J Jamieson et al.   LANCET

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

(2009) Xiao-Feng Liang et al.   LANCET

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial

(2009) Zoltan Vajo et al.   LANCET

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses

(2009) Ken M Kunisaki et al.   LANCET INFECTIOUS DISEASES

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

(2009) Michael E. Greenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Historical Perspective — Emergence of Influenza A (H1N1) Viruses

(2009) Shanta M. Zimmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

(2009) Feng-Cai Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine

(2009) Tristan W. Clark et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

(2009) Kathy Hancock et al.   NEW ENGLAND JOURNAL OF MEDICINE